Pasar al contenido principal

Advanced Biomedical Optic Systems for Vision Testing and Retinal Imaging

RYC2021-033355-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Simulation of daily soft multifocal contact lenses using SimVis Gekko: from in-vitro and computational characterization to clinical validation

  • Esteban-Ibañez, Eduardo
  • Montagud-Martínez, Diego
  • Sawides, Lucie
  • Zaytouny, Amal
  • de Castro, Alberto
  • Sisó-Fuertes, Irene
  • Barcala, Xoana
  • Piñero, David P.
  • Furlan, Walter D.
  • Dorronsoro, Carlos
  • Gambra, Enrique
[EN] Multifocal contact lenses (MCLs) are one of the solutions to correct presbyopia, but their adoption is not widespread. To address this situation, visual simulators can be used to refine the adaptation process. This study aims to obtain accurate simulations for a visual simulator (SimVis Gekko; 2EyesVision) of daily soft MCL designs from four manufacturers. In-vitro characterization of these MCLs-several powers and additions- was obtained using NIMO TR-1504. From the averaged relative power profiles across powers, phase maps were reconstructed and the Through-Focus Visual Strehl metric was calculated for each MCL design. The SimVis Gekko simulation corresponding to each MCL design was obtained computationally and bench-validated. Finally, the MCL simulations were clinically validated involving presbyopic patients. The clinical validation results show a good agreement between the SimVis Gekko simulations and the real MCLs for through-focus visual acuity (TF-VA) curves and VA at three real distances. All MCL designs showed a partial correlation higher than 0.90 and a Root Mean Square Error below 0.07 logMAR between the TF-VA of simulations and Real MCLs across subjects. The validity of the simulation approach using SimVis Gekko and in-vitro measurements was confirmed in this study, opening the possibility to accelerate the adaptation of MCLs., Tis work was supported by multiple funding sources, including the Madrid Regional Government under the Industrial Doctorate Grant (IND2020/BMD-17442) to E.E-I. and A.Z., the Ministerio de Universidades, Spain (funded by the European Union Next Generation EU) under the Margarita Salas Grant to D.M.-M. and the Ministerio de Ciencia e Innovación, Spain, under Ayudas a proyectos de colaboración publico-privada (CPP2021-008388) to A.d.C. and C.D., Torres Quevedo Grant (PTQ2021-011963) to I.S.-F. and Ramon y Cajal Grant (RYC2021-033355-I) to L.S.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Simulation of daily soft multifocal contact lenses using SimVis Gekko: from in-vitro and computational characterization to clinical validation

  • Esteban-Ibañez, Eduardo
  • Montagud-Martínez, Diego
  • Sawides, Lucie
  • Zaytouny, Amal
  • de Castro, Alberto
  • Sisó-Fuertes, Irene
  • Barcala, Xoana
  • Piñero, David P.
  • Furlan, Walter D.
  • Dorronsoro, Carlos
  • Gambra, Enrique
  • Piñero, David P.|||/items/02d2ffcc-a108-4e8d-ad21-df3b3fc92a22
Multifocal contact lenses (MCLs) are one of the solutions to correct presbyopia, but their adoption is not widespread. To address this situation, visual simulators can be used to refine the adaptation process. This study aims to obtain accurate simulations for a visual simulator (SimVis Gekko; 2EyesVision) of daily soft MCL designs from four manufacturers. In-vitro characterization of these MCLs—several powers and additions- was obtained using NIMO TR-1504. From the averaged relative power profiles across powers, phase maps were reconstructed and the Through-Focus Visual Strehl metric was calculated for each MCL design. The SimVis Gekko simulation corresponding to each MCL design was obtained computationally and bench-validated. Finally, the MCL simulations were clinically validated involving presbyopic patients. The clinical validation results show a good agreement between the SimVis Gekko simulations and the real MCLs for through-focus visual acuity (TF-VA) curves and VA at three real distances. All MCL designs showed a partial correlation higher than 0.90 and a Root Mean Square Error below 0.07 logMAR between the TF-VA of simulations and Real MCLs across subjects. The validity of the simulation approach using SimVis Gekko and in-vitro measurements was confirmed in this study, opening the possibility to accelerate the adaptation of MCLs.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Simulation of daily soft multifocal contact lenses using SimVis Gekko: from in-vitro and computational characterization to clinical validation

  • Esteban-Ibañez, Eduardo
  • Montagud-Martínez, Diego
  • Sawides, L.
  • Zaytouny, Amal
  • Castro, Alberto de
  • Sisó-Fuertes, Irene
  • Barcala, Xoana
  • Piñero, David P.
  • Furlan, Walter D.
  • Dorronsoro, Carlos
  • Gambra, Enrique
11 pags., 5 figs., 2 tabs., Multifocal contact lenses (MCLs) are one of the solutions to correct presbyopia, but their adoption is not widespread. To address this situation, visual simulators can be used to refine the adaptation process. This study aims to obtain accurate simulations for a visual simulator (SimVis Gekko; 2EyesVision) of daily soft MCL designs from four manufacturers. In-vitro characterization of these MCLs-several powers and additions- was obtained using NIMO TR-1504. From the averaged relative power profiles across powers, phase maps were reconstructed and the Through-Focus Visual Strehl metric was calculated for each MCL design. The SimVis Gekko simulation corresponding to each MCL design was obtained computationally and bench-validated. Finally, the MCL simulations were clinically validated involving presbyopic patients. The clinical validation results show a good agreement between the SimVis Gekko simulations and the real MCLs for through-focus visual acuity (TF-VA) curves and VA at three real distances. All MCL designs showed a partial correlation higher than 0.90 and a Root Mean Square Error below 0.07 logMAR between the TF-VA of simulations and Real MCLs across subjects. The validity of the simulation approach using SimVis Gekko and in-vitro measurements was confirmed in this study, opening the possibility to accelerate the adaptation of MCLs., This work was supported by multiple funding sources, including the Madrid Regional Government under the Industrial Doctorate Grant (IND2020/BMD-17442) to E.E-I. and A.Z., the Ministerio de Universidades, Spain (funded by the European Union Next Generation EU) under the Margarita Salas Grant to D.M.-M. and the Ministerio de Ciencia e Innovación, Spain, under Ayudas a proyectos de colaboración publico-privada (CPP2021008388) to A.d.C. and C.D., Torres Quevedo Grant (PTQ2021-011963) to I.S.-F. and Ramon y Cajal Grant (RYC2021-033355-I) to L.S., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Perceptual cost and benefit of presbyopia-correcting intraocular lenses: effect of energy balance, addition, and adaptation

  • Esteban-Ibañez, Eduardo
  • Gambra, Enrique
  • Marrakchi, Yassine
  • Sawides, L.
  • Dorronsoro, Carlos
23 pages, 12 figures, 1 table, Presbyopic intraocular lenses (IOLs) based on simultaneous vision represent a compromise between perceptual benefit and cost at near and far distances. We evaluated this compromise for simulated bifocal IOLs with varying energy distributions and additions using SimVis Gekko under different adaptation conditions. Presenting multifocal corrections after a blur adaptation with an abrupt transition of at least 5s improves acceptance. Smooth transitions to multifocality of at least 5s also improve acceptance, independently of previous adaptation. Corrections with low additions show more visual degradation at far without equivalent benefit at near. These results can be useful for IOL designers and clinicians to maximize multifocal adoption of IOLs., Ministerio de Ciencia, Innovación y Universidades (CPP2021-008388, RYC2021-033355-I); Comunidad de Madrid (IND2020/BMD-17442)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Predictions of Through-Focus Performance of Presbyopia-Correcting Intraocular Lenses in Presbyopic Subjects Using a Visual Simulator

  • Papadogiannis, Petros
  • Barcala, Xoana
  • Sisó-Fuertes, Irene
  • Zaytouny, Amal
  • Sawides, L.
  • Dorronsoro, Carlos
  • Marcos, Susana
To validate whether visual simulations of multifocal intraocular lenses and extended depth of focus (EDOF) intraocular lenses (IOLs) in phakic presbyopes replicate postoperative vision, and to compare performance across these lenses in the same subject., Financial support – Ministerio de Ciencia, Innnovación y Universidades CPP2021-008388, PID2023-152641OA-I00, PID2020-115191RB-I00; Grants – RETOS CPP2021-008388; Royalties – 2EyesVision, PhysIOL BVI, Plenoptika; Travel expenses – 2EyesVision; Patents – P201232043, P201331436, P201531397; Participation on a Data Safety Monitoring Board – 2EyesVision; Leadership – 2EyesVision; Stock and receipt of equipment – 2EyesVision., Financial support – PID2023-152641OA-I00 from Ministerio de Ciencia, Innnovación y Universidades; Grants –RYC2021-033355-I, Ministerio de ciencia e Innovación, IND2023/BMD-27723, Comunidad de Madrid; Leadership – Instituto de Óptica, CSIC; Stock – 2EyesVision., Financial support – Ministerio de Ciencia, Innnovación y Universidades CPP2021-008388, PID2023-152641OA-I00, PID2020-115191RB-I00; Grants – Empire State Development Funds, New York State, Center for Emerging and Innovative Science, Empire State Development Funds, New York State, Center of Excellence in Data Science, National Eye Institute, National Institutes of Health, Research to Prevent Blindness, Zeiss, Stuart Therapeutics, Clerio Vision Inc, Bausch and Lomb, Alcon, CooperVision; Royalties – 2EyesVision, PhysIOL BVI, Plenoptika; Consultant – 2Eyesvision, Adaptilens, AzaleaVision, Hoya; Honoraria – National Academies of Sciences, Elsevier; Travel expenses – 2EyesVision, National Academies of Sciences, European Society for Cataract and Refractive Surgery, Optica; Patents – P201232043, P201331436, P201531397, UR: 2-25038-PROV, UR: 2-25050-PROV; Participation on a Data Safety Monitoring Board – 2EyesVision, Azalea, Hoya; Stock – 2EyesVision, Plenoptika; Receipt of equipment – 2EyesVision, Stuart Therapeutics, Reality Labs. Supported by the Ministerio de Ciencia e Innovación, Spain (CPP2021-008388, PID2023-152641OA-I00, and PID2020-115191RB-I00). The funding organizations had no role in the design or conduct of this research., Peer reviewed